Methyldopa use should be restricted
dc.contributor.author | de Silva, H.A. | en_US |
dc.contributor.author | Hewavisenthi, J. | en_US |
dc.contributor.author | Wijesiriwardena, B. | en_US |
dc.contributor.author | Fonseka, M.M.D. | en_US |
dc.creator.corporateauthor | Sri Lanka Medical Association | en_US |
dc.date.accessioned | 2014-10-29T09:18:22Z | |
dc.date.available | 2014-10-29T09:18:22Z | |
dc.date.issued | 1999 | en_US |
dc.description.abstract | No Abstract Available | |
dc.identifier.citation | The Ceylon Medical Journal. 1999; 44(4): pp.188-189 | en_US |
dc.identifier.department | Pharmacology | en_US |
dc.identifier.department | Pathology | en_US |
dc.identifier.issn | 0009-0875 (Print) | en_US |
dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/1403 | |
dc.publisher | Sri Lanka Medical Association | en_US |
dc.subject | Methyldopa | en_US |
dc.subject | Hypertension-drug therapy | |
dc.subject | Methyldopa-adverse effects | |
dc.subject | Methyldopa-contraindications | |
dc.subject | Antihypertensive Agents | |
dc.subject | Antihypertensive Agents-adverse effects | |
dc.title | Methyldopa use should be restricted | en_US |
dc.type | Letter | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: